Does MEPOLIZUMAB Cause Activated partial thromboplastin time prolonged? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Activated partial thromboplastin time prolonged have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.0% of all adverse event reports for MEPOLIZUMAB.
13
Reports of Activated partial thromboplastin time prolonged with MEPOLIZUMAB
0.0%
of all MEPOLIZUMAB reports
12
Deaths
11
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From MEPOLIZUMAB?
Of the 13 reports, 12 (92.3%) resulted in death, 11 (84.6%) required hospitalization, and 11 (84.6%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which MEPOLIZUMAB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE